Elite Pharmaceuticals (ELTP) Return on Equity [ROE] (2016 - 2026)
Elite Pharmaceuticals' Return on Equity [ROE] was 55.64% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 77.18 percentage points from -21.54% a year earlier and up 5.55 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Equity [ROE] at Elite Pharmaceuticals came in at 58.89%, up 66.81 percentage points from FY2025.
- Return on Equity [ROE] shows a five-year change of +27.97 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Equity [ROE] was -7.92% in FY2025 (-54.48 pp), 46.56% in FY2024 (+33.41 pp), 13.15% in FY2023 (-25.72 pp) and 38.87% in FY2022 (+7.95 pp).
- Quarterly Return on Equity [ROE] has moved between -42.88% (fiscal Q3 2025) and 61.06% (fiscal Q3 2026) over five years.
- Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +4.76 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q3 2026 (a gain of 103.95 percentage points); the worst was fiscal Q3 2025 (a drop of 76.88 percentage points).
- Per Business Quant data, ELTP's Return on Equity [ROE] in the three fiscal quarters before Q1 2027 was 50.08% (Q4 2026), 61.06% (Q3 2026) and 25.33% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | - |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 4.97% |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 55.64% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.64% |
| Mar 31, 2026 | 50.08% |
| Dec 31, 2025 | 61.06% |
| Sep 30, 2025 | 25.33% |
| Jun 30, 2025 | -21.54% |
| Mar 31, 2025 | -9.78% |
| Dec 31, 2024 | -42.88% |
| Sep 30, 2024 | -12.04% |
| Jun 30, 2024 | 33.88% |
| Mar 31, 2024 | 38.74% |
| Dec 31, 2023 | 33.99% |
| Sep 30, 2023 | 47.38% |
| Jun 30, 2023 | 14.89% |
| Mar 31, 2023 | 12.04% |
| Dec 31, 2022 | 25.17% |
| Sep 30, 2022 | 24.78% |
| Jun 30, 2022 | 26.85% |
| Mar 31, 2022 | 33.50% |
| Dec 31, 2021 | 23.70% |
| Sep 30, 2021 | 24.78% |
Elite Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();